Compare KNTK & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | KNTK | GPCR |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | |
| Sector | Utilities | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.8B |
| IPO Year | 2017 | 2023 |
| Metric | KNTK | GPCR |
|---|---|---|
| Price | $51.29 | $29.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 16 |
| Target Price | $57.31 | ★ $105.78 |
| AVG Volume (30 Days) | ★ 963.3K | 914.2K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | ★ 6.45% | N/A |
| EPS Growth | ★ 157.84 | N/A |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $160,617,000.00 | N/A |
| Revenue This Year | $16.68 | N/A |
| Revenue Next Year | $14.16 | N/A |
| P/E Ratio | $84.11 | ★ N/A |
| Revenue Growth | ★ 8.23 | N/A |
| 52 Week Low | $31.33 | $25.59 |
| 52 Week High | $56.92 | $94.90 |
| Indicator | KNTK | GPCR |
|---|---|---|
| Relative Strength Index (RSI) | 30.31 | 21.44 |
| Support Level | $44.64 | N/A |
| Resistance Level | $51.72 | $56.63 |
| Average True Range (ATR) | 1.42 | 1.79 |
| MACD | -0.51 | -0.27 |
| Stochastic Oscillator | 12.12 | 7.79 |
Kinetik Holdings Inc is a midstream operator that provides comprehensive gathering, transportation, compression, processing and treating services. Its activities also include NGL stabilization and transportation, produced water gathering and disposal, and crude oil gathering, stabilization, storage, and transportation. The company operates in two reportable segments: i) The Midstream Logistics segment operates under three service offerings: 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. ii) The Pipeline Transportation segment consists of two EMI Pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.